Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / AirNexis Therapeutics
Entity

AirNexis Therapeutics

Tracked across 2 events · 13 articles · First seen Jan 02, 2025 · Last active Jun 12, 2026

Sentiment
10
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 20
Tech
Kalaris Therapeutics Presents TH103 Data
Impact: AirNexis Therapeutics is presenting Phase 1a clinical data for its lead asset, TH103, which could positively impact its stock price and future development.
Jun 12, 2026 · 6 articles
4 0
Business
Galera and Obsidian Therapeutics Merger
Impact: The CEO of AirNexis Therapeutics, Maria Fardis, will chair the Board of Directors of the combined company.
Apr 14, 2026 · 7 articles
ERGEN INTELLIGENCE
Track AirNexis Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.